Forepont Capital Partners is a Medtech and biotech focused venture capital firm which was founded in 2017, headquartered in New York with a presence in Europe. Our mission is to invest in biotech, medtech and digital-health start-ups in the US and Europe while providing scientific, technological financial and operational support. The fund has developed strong and tight partnerships with industry leaders (researchers, hospitals, academia, large pharmaceutical groups) who have vastly contributed to the performance of the existing portfolio, and that contributed to generating a proprietary deal flow.
